Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

about

Alteration of brainstem raphe measured by transcranial sonography in depression patients with or without Parkinson's disease.

P2860

Q48076337-EA577C71-1928-4286-A246-5E8718612064

P2860

Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

Item

http://www.wikidata.org/entity/Q38265929

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Depression in Parkinson's dise ...... rmacotherapy. Clinical review.

@en

type

Item

label

Depression in Parkinson's dise ...... rmacotherapy. Clinical review.

@en

prefLabel

Depression in Parkinson's dise ...... rmacotherapy. Clinical review.

@en

P1476

Depression in Parkinson's dise ...... rmacotherapy. Clinical review.

@en

P2093

Agnieszka Dyduch

http://www.w3.org/2001/XMLSchema#string

Maria Załuska

http://www.w3.org/2001/XMLSchema#string

P2860

Therapies for depression in Parkinson's disease

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

Psychiatric care in Parkinson's disease.

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

Increased risk of Parkinson's disease after depression: a retrospective cohort study.

Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.

P304

147-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PSYG.12078

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267812461

http://www.w3.org/2001/XMLSchema#string

P698

25377773

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

about

P2860

P2860

Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921